TREATMENT OF IRON DEFICIENCY ANAEMIA IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE USING FERROUS SULPHATE OR COSMOFER: TOLERANCE AND EFFECTS ON HAEMOGLOBIN, DISEASE ACTIVITY, MOOD, QUALITY OF LIFE AND AUTONOMIC NERVOUS SYSTEM ACTIVITY. AN OPEN LABEL PHASE IV NON-INFERIORITY STUDY. - TREATMENT OF IRON DEFICIENCY ANAEMIA IN ADOLESCENTS WITH IBD.

Barts Health NHS Trust0 个研究点目标入组 88 人开始时间: 2011年7月16日最近更新: 2019年6月30日

适应症

试验速览

暂无简介。

•Patients with IDA complicating their IBD. Anaemia will be defined by age and sex-adjusted World Health Organisation criteria. Because serum ferritin is an acute phase reactant, patients with iron deficiency will be defined by a transferrin saturation <16%.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 0
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 0

•- Patients who cannot read English, as not all of the questionnaires in the study have been validated in Non-English languages.
•- Patients who present to the clinic and who are overtly ill requiring admission will also be excluded.
•- Patients who are anaemic for a different reason, including folic acid, B12 deficiency, as a result of thiopurine use (pancytopenia), or with co-existent haemaglobinopathies or myelodysplasia.
•- Patients under the age of 13 and over the age of 90.
•- Patients with severe cardiopulmonary disease, hepatic or renal impairment, pregnancy, alcohol or drug abuse.

发起方